Abstract
Nephrotoxicity is a common and often clinically relevant adverse drug reaction. Mechanisms include vascular, tubulo-toxic, tubulo-obstructive, and immunological effects. Drug-drug interactions may occur at a pharmacokinetic or pharmacodynamic level. Such interactions can both increase (cisplatin and aminoglycoside) but also protect from nephrotoxicity (cidofovir and probenecid).Important measures for preventing nephrotoxicity are (1) consideration of potential pharmacokinetic and pharmacodynamic interactions when prescribing a drug, (2) prescription of nephrotoxic drugs for the shortest possible period, (3) detection of high-risk patients, and (4) consideration of hydration and prophylactic comedication.
MeSH terms
-
Aminoglycosides / pharmacokinetics
-
Aminoglycosides / toxicity
-
Analgesics / pharmacokinetics
-
Analgesics / toxicity
-
Anti-Bacterial Agents / pharmacokinetics
-
Anti-Bacterial Agents / toxicity
-
Anti-HIV Agents / pharmacokinetics
-
Anti-HIV Agents / toxicity
-
Antineoplastic Agents / pharmacokinetics
-
Antineoplastic Agents / toxicity
-
Antirheumatic Agents / pharmacokinetics
-
Antirheumatic Agents / toxicity
-
Cidofovir
-
Cisplatin / pharmacokinetics
-
Cisplatin / toxicity
-
Contrast Media / pharmacokinetics
-
Contrast Media / toxicity
-
Creatinine / blood
-
Cytosine / analogs & derivatives
-
Cytosine / pharmacokinetics
-
Cytosine / toxicity
-
Drug Interactions*
-
Drug-Related Side Effects and Adverse Reactions*
-
Humans
-
Kidney / drug effects*
-
Organophosphonates / pharmacokinetics
-
Organophosphonates / toxicity
-
Probenecid / pharmacokinetics
-
Probenecid / toxicity
-
Risk Factors
-
Uricosuric Agents / pharmacokinetics
-
Uricosuric Agents / toxicity
Substances
-
Aminoglycosides
-
Analgesics
-
Anti-Bacterial Agents
-
Anti-HIV Agents
-
Antineoplastic Agents
-
Antirheumatic Agents
-
Contrast Media
-
Organophosphonates
-
Uricosuric Agents
-
Cytosine
-
Creatinine
-
Cidofovir
-
Probenecid
-
Cisplatin